Palo Alto, CA – June 11, 2025 – BioTools Innovator Accelerator is the first and only program focused exclusively on life science tools and diagnostics companies. Avenue Biosciences is proud to be among the 31 companies selected to the 2025 BioTools Innovator Accelerator program from over 400 applicants.
Becoming a member of the BioTools Innovator community provides support and resources for developing novel tools that accelerate biologics production and development.
Avenue Biosciences’ first-to-market protein engineering technology employs a high throughput approach to optimize signal peptides and maximize protein expression. The technology has a broad applicability across mRNA therapies, gene therapy vectors, antibody engineering, biosimilars, de novo proteins and more.
BioTools Innovator Accelerator in short:
- A prestigious, four-month accelerator program offering tailored mentorship from senior industry leaders, investor exposure, and networking opportunities.
- Chosen from a highly competitive pool of more than 400 applicants, the selected companies represent the top 7% of applicants.
- At the end of the program, companies will compete for $300,000 in non-dilutive cash prizes.
Read BTI Press release here.
About Avenue Biosciences
Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Based inSan Francisco, USA, and Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biology and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. www.avenuebiosciences.com
About BioTools Innovator
BioTools Innovator, based in Los Angeles, advances cutting-edge research and improves human health by accelerating the growth of life science tools and diagnostics startups. Powered by MedTech Innovator, the world’s largest accelerator for medical technology companies, BTI supports early-stage and emerging growth companies through mentorship, visibility, and non-dilutive funding opportunities. Learn more at https://biotoolsinnovator.org.
CEO Tero-Pekka Alastalo in San Diego. Credit: BioTools Innovator.
